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doi:10.1016/j.ejvs.2010.03.024Abstract Objective: Reactive oxygen and nitrogen species (e.g., peroxynitrite) may trigger
neointima formation leading to restenosis. In a rat carotid endarterectomy (CEA) model, we
investigated the effects of the manganese(III)tetrakis(4-benzoic acid)porphyrin (MnTBAP),
a superoxide dismutase (SOD) mimetic and peroxynitrite scavenger on neointima formation.
Methods: CEA was performed in male SpragueeDawley rats. Animals received either vehicle
(control group; nZ 15) or 15 mg kg1 day1 MnTBAP intraperitoneally for 3 weeks (treatment
group; nZ 13). Four groups of carotids were analysed: the left, uninjured carotids (sham) and
the right, injured carotids (control CEA) from the control group, the right, injured carotids
from the treatment group (CEAþMnTBAP) and an additional group of carotids that were har-
vested 1 h following endarterectomy. The analysis of carotid arteries was performed by
histology, immunohistochemistry and real-time polymerase chain reaction (PCR). Plasma mal-
ondialdehyde (MDA) levels were measured by lipid hydroperoxidase assay.
Results: Stenosis rate (10.5 8.1% vs. 45.4 28.3%), the percentage of proliferating cell nuclear
antigen-positive cells (13.4 7.1% vs. 23.3 11.0%) and nitrotyrosine immunoreactivity (5.8
 1.9 vs. 8.0 2.0) were significantly reduced in the vascular wall of the CEAþMnTBAP group
compared with control CEA group. Ratio of Terminal deoxynucleotidyl transferase-mediated
dUTP-biotin nick end labelling (TUNEL)-positive nuclei was significantly lower after antioxidant
therapy (41.7  26.7% vs. 64.9  18.5%). Plasma MDA levels increased after endarterectomy
(11.7 4.8 vs. 4.1 2.0 mmol l1) and reduced in the treatment group (3.2 2.1 mmol l1). No
significant gene regulation after MnTBAP treatment could be noted.rg. Experimental Laboratory of Cardiac Surgery, Im Neuenheimer Feld 326, II. OG, 297a, 69120 Hei-
095; fax: þ49 6221 564571.
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MnTBAP Protects Against Neointima Formation 169Conclusions: MnTBAP decreased neointima formation, which was associated with reduced
vascular smooth muscle cell proliferation and attenuated local and systemic nitro-oxidative
stress.
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complication of both percutaneous and open vascular
procedures. The incidence of restenosis is variable, accord-
ing to the revascularisation method, the vascular area (e.g.,
coronary, carotid or peripheral arteries) and according to
many other factors. After conventional coronary balloon
angioplasty, restenosis rate reached 30e50% that could be
diminished by bare metal stents (10e30%) and could be
further reduced by drug-eluting stents.1 Restenosis devel-
opment after vascular injury (e.g., endarterectomy, angio-
plasty and stenting) is characterised by interrelated
processes, such as platelet activation, inflammation,
vascular smooth muscle cell (VSMC) migration/proliferation
and extracellular matrix deposition.1,2 The latter two are
finally responsible for neointimal hyperplasia leading to
recurrent stenosis of the treated vessels. The main factors
that trigger the above-mentioned processes are endothelial
damage and subsequent generation of reactive oxygen and
nitrogen species (ROS andRNS), such as superoxide anion and
peroxynitrite.3 ROS and RNS participate during the whole
course of restenosis development by activation of signalling
pathways involved in neointima formation or by regulating
the expression of redox-sensitive genes.4 The vascular
reduced nicotinamide adenine dinucleotide (phosphate)
(NAD(P)H) oxidases are the primary producers of ROS, while
superoxide dismutase-1 (SOD-1 or CuZnSOD) is primarily
responsible for ROS removal.3,5 ROS can induce the expres-
sion of pro-inflammatory genes and superoxide anions
enhance the catabolismof nitric oxide (NO) via the formation
of peroxynitrite.6,7
Antioxidant drugs that reduce ROS/RNS levels have been
represented for several years as important therapeutic targets
for the treatment of restenosis.4,8,9 However, the clinical effi-
cacy of free radical scavengers has been limited due to their
short half-life and low penetration in vascular tissues. Manga-
nese(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a cell-
permeable SODmimetic and peroxynitrite scavenger, has been
suggested to exert protective effects in several pathophysio-
logic conditions in association with oxidative stress.7,10e12
The present study was designated to evaluate the
association between neointimal hyperplasia and local as
well as systemic signs of oxidative and nitrosative stress
after vascular injury in a rat carotid endarterectomy (CEA)
model established in our laboratory. In addition, we aimed
to test the effects of the antioxidant MnTBAP on neointimal
hyperplasia and gene regulation during stenosis formation.Methods
Rat CEA
The protocol was approved by the Regional Ethical
Committee for Laboratory Animal Use and conformed withthe Guide for the Care and Use of Laboratory Animals
published by the United States National Institutes of Health
(NIH Publication No. 85e23, revised 1996). Thirty-two male
SpragueeDawley rats (250e300 g body weight) underwent
right CEA as described previously.13 Briefly, after adequate
anaesthesia with an intraperitoneal injection of ketamine
hydrochloride (100 mg kg1) and xylazine hydrochloride
(5 mg kg1), the right common carotid artery was exposed
under a dissecting microscope via a midline cervical inci-
sion. After clamping of the right common carotid artery, it
was punctured by a 27-G needle and the arteriotomy was
extended to 6 mm with microscissors. To denude the
endothelium, a sterile cotton-tipped applicator immersed
in saponin (0.1%) was rubbed on the inner vessel surface.
The arteriotomy was closed with a running 9/0 Ethilon
monofilament nylon suture (Ethicon, Inc, Somerville, NJ,
USA). The superficial cervical muscles and skin were closed
with running 4/0 absorbable sutures. Animals were placed
postoperatively on a standard rat diet and provided with
water ad libitum.Experimental groups
Animals were randomly assigned into three groups: (1)
control CEA group (nZ 15) treated with placebo and (2) the
treatment group (nZ 13) that underwent CEA and received
MnTBAP (21 days, 15 mg kg1 day1, administered intra-
peritoneally) dissolved in 0.1 M TriseHCl, 1 mM ethyl-
enediamine tetraacetic acid (EDTA), pH 9.00. This dose was
drawn from recent literature reports showing the efficacy
of MnTBAP in rat models.10 In addition (3), four rats
underwent CEA and the carotid arteries were harvested 1 h
following surgery. Carotid arteries from the above-
mentioned three experimental groups were divided into
four groups: left, uninjured carotids from the control
endarterectomy group (sham); carotid arteries harvested
1 h after endarterectomy (acute injury group); right,
injured carotids from the control endarterectomy group
(control CEA) and right, injured carotids from the treat-
ment group (CEAþMnTBAP).Histologic analysis
After 21 days, 10 carotids fromboth the shamandcontrol CEA
groups and nine carotids from the CEAþMnTBAP group were
perfusion-fixed and harvested. First, EDTA-anticoagulated
blood was taken from the inferior caval vein, then the vein
was transected and the heart was cannulated. Normal saline
solution was infused at 100 mmHg until the vena cava
effluent ran clear, and then a solution of 4% formaldehyde
was infused at a constant pressure of 100 mmHg in an equal
volume to the saline infusion (200 ml) to complete the per-
fusionefixation process. Morphometry was performed in
170 K. Hirschberg et al.three haematoxylineeosin stained cross-sections of each
animal (from themid region of the operated vessel segment)
by using computer-aided planimetry (BX51 microscope and
Cell^A imaging software, Olympus, Hamburg, Germany). For
a detailed description, see the online-only Data Supplement.
Immunohistochemical staining
Immunohistochemical analysis was done in one represen-
tative cross-section of each animal using the avidinebiotin
method. Proliferating cell nuclear antigen (PCNA), nitro-
tyrosine (NT) and transforming growth factor b1 (TGFb1)
were determined. Immunohistochemical stainings were
evaluated by a semiquantitative scoring system with the
Cell^A imaging software (Olympus, Hamburg, Germany).
For a detailed description, see the online-only Data
Supplement.TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick end labelling (TUNEL) was used to detect DNA
fragmentation that results from oxidative DNA damage. For
a detailed description of the TUNEL assay, see the online-
only Data Supplement.Quantitative real-time reverse transcription-
polymerase chain reaction (RT-qPCR)
Five carotids from both the sham and the control CEA
groups and four carotids from both the acute injury and
CEAþMnTBAP groups were perfused with ice-cold saline
solution, harvested and immediately snap-frozen in liquid
nitrogen. Operated segments of the carotids were ground
under liquid nitrogen in a pestle and mortar, and total RNA
was extracted using RNeasy Fibrous Tissue Mini Kit (Quia-
gen, Hilden, Germany) according to the manufacturer’s
instructions. RNA concentration and purity were deter-
mined photometrically (at 260, 280 and 230 nm). RNA
(1.4 mg from each group) was reverse-transcribed with
QuantiTect Reverse Transcription Kit (Quiagen, Hilden,
Germany). Real-time PCR reactions were performed on the
Light Cycler 480 Real-time PCR detection system using the
Light Cycler 480 Probes Master and Universal Probe Library
(UPL) probes (Roche, Mannheim, Germany). Expression of
genes involved in inflammation, proliferation and extra-
cellular matrix metabolism during neointima formation was
determined. For more details, see the online-only Data
Supplement and Online Table 1.Lipid hydroperoxidase assay
EDTAeanticoagulated blood samples were collected from
each animal in the control CEA and CEAþMnTBAP groups.
In addition, blood samples were taken from five animals
that did not undergo an operation or treatment (sham).
Plasma was separated and placed immediately in liquid
nitrogen. Malondialdehyde (MDA) level was measured by
a lipid hydroperoxidase (LPO) assay kit following theprotocol provided by the manufacturer (Calbiochem,
Merck, Germany).
Statistical analysis
Values are expressed as mean standard deviation.
Statistical analysis was performed by using the Origin 7
statistical software product. Two group comparisons were
performed by Student’s t-test. A value of p< 0.05 was
considered statistically significant.
Results
Neointimal thickening is suppressed by MnTBAP
Three weeks after endarterectomy, neointimal thickening
was found in the carotids of the control endarterectomy
group, resulting in a 45.41% stenosis of the original luminal
area (Fig. 1A, D). In the MnTBAP treated group, significant
reductionof neointima formationwasobserved. Stenosiswas
10.48% in this group (p< 0.05, CEAþMnTBAP group
compared with control CEA group) (Fig. 1A, E). Further
parametersmeasured in the carotid arteries are shown in the
Online Table 2. Vessel area and media area showed no
significant differences between sham, control CEA and
CEAþMnTBAP groups. Total neointima area and neointimal
thickness were higher in the control CEA group as compared
with sham, and significantly lower in the CEAþMnTBAP
group as compared with control CEA group (Online Table 2).
In addition, the neointimal/medial area ratio was calculated
and was found to be significantly reduced after MnTBAP
treatment (0.27 vs. 0.76 in the CEAþMnTBAP group vs. the
control CEA group, p< 0.05) (Fig. 1B). In the sham group,
normal morphologic structure was found with a single
endothelial cell layer as shown in Fig. 1C.Proliferation rate and nitro-oxidative stress is
decreased after MnTBAP treatment
PCNA immunohistochemical staining is a common method
to confirm cell proliferation activity after arterial injury. As
shown in Fig. 2, the proportion of PCNA-positive cell nuclei
in the vascular media was significantly higher in the control
CEA group as compared with sham. Both in the medial and
neointimal layer, PCNA-positivity significantly decreased in
the CEAþMnTBAP group compared with control CEA group
(Fig. 2AeE). On the other hand, TGFb1 immunoreactivity
was similar in all the three experimental groups
(Fig. 2FeJ). In the media of the control CEA group, there is
a tendency for increased nitrosative stress as shown by
higher nitrotyrosine immunoreactivity. Peroxynitrite
formation is significantly decreased in the media of the
CEAþMnTBAP group compared with the control CEA group.
When analysing the neointimal layer only, the difference
was not significant (Fig. 2KeO). In this study, the nonspe-
cific TUNEL assay was used to assess medial and neointimal
cells with oxidative DNA injury during stenosis formation.
Indeed, an approximately sixfold increase in the number of
TUNEL-positive medial smooth muscle cells occurred in the
control CEA group compared with sham, proving an
Figure 1 Morphometric results and representative histologic cross-sections from the different groups. A, luminal stenosis. B,
neointima/media area ratio. C, sham (nZ 10). D, control CEA (nZ 10). E, CEAþMnTBAP (nZ 9). *p< 0.05 vs. sham; #p< 0.05 vs.
control CEA.
MnTBAP Protects Against Neointima Formation 171excessive oxidative stress caused by endarterectomy, that
persists 3 weeks after arterial injury. MnTBAP markedly
decreased the amount of TUNEL-positive cells in the
vascular wall; however, the difference was only significant
in the medial but not in the neointimal layer (Fig. 3).Figure 2 Representative photomicrographs (AeC, FeH, KeM) an
chemical stainings for proliferating cell nuclear antigene (PCNA, pu
brown staining, FeJ), and for nitrotyrosine (brown staining, KeO)
represent the sham group (nZ 10); B, G, L represent the control ca
represent the treatment group (nZ 9). *p< 0.05 vs. sham; #p< 0.Decreased oxidative stress in the CEAþMnTBAP group
could be confirmed by lipid hydroperoxidase assay as well.
Three weeks after CEA, plasma MDA level increased 2.86-
fold compared with those of the sham animals
(11.70 4.77 mmol l1 vs. 4.09 2.03 mmol l1). A highlyd semiquantitative scoring (DeE, IeJ, NeO) of immunohisto-
rple/red staining, AeE) transforming growth factor b1 (TGFb1,
in the medial (D, I, N) and neointimal layer (E, J, O). A, F, K
rotid endarterectomy (control CEA) group (nZ 10) and C, H, M
05 vs. control CEA.
Figure 4 Malondialdehyde (MDA) plasma concentrations in
animals of the sham (nZ 5), control CEA (nZ 15) and
CEAþMnTBAP (nZ 13) groups. *p< 0.05 vs. sham; #p< 0.05
vs. control CEA.
172 K. Hirschberg et al.significant decrease could be observed after MnTBAP
treatment (3.15 2.19 mmol l1 in the CEAþMnTBAP group
vs. 11.70 4.77 mmol l1 in the control CEA group) (Fig. 4).
Gene expression is not significantly affected by
MnTBAP during stenosis formation
The relative expression of endothelial nitric oxide synthase
(eNOS) in the carotid artery was decreased 10-fold 1 h after
endarterectomy, confirming effective endothelial damage.
Three weeks after endothelial denudation, eNOS expression
reached the level of those in the sham group, confirming
a re-endothelialisation process. MnTBAP slightly increased
eNOS expression; however, the difference was not signifi-
cant (Fig. 5A). TGFb1 expression did not change 1 h after
endarterectomy and was twofold up-regulated 3 weeks
after injury. MnTBAP exerted no effects on TGFb1 gene
expression (Fig. 5B). Vascular NAD(P)H oxidase (NOX-4) was
up-regulated in the control CEA group, while superoxide
dismutase-1 was down-regulated. The expression of both
markers of oxidative stress remained unchanged in the
CEAþMnTBAP group (Fig. 5C, D). Proto-oncogenes c-JUN
and c-FOS were overexpressed 1 h after endothelial injury
and decreased to the level of the sham group in 3 weeks.
MnTBAP further decreased c-FOS expression, while those of
c-JUN remained unchanged (Fig. 5E, F). Matrix-metal-
loproteinase-2 (MMP-2) significantly decreased 1 h as well
as 3 weeks after endarterectomy, while MMP-9 was up-
regulated at both time intervals. MnTBAP had no effects on
the expression of both MMP genes (Fig. 5G, H).
Discussion
Reactive oxygen and nitrogen species play important role in
neointima formation that leads to restenosis, which isFigure 3 Ratio (%) of TUNEL-positive (brown) nuclei in the medi
photomicrographs of the TUNEL assay in the sham (C, nZ 10), con
vs. sham; #p< 0.05 vs. control CEA.supported by several previous works.4,8,14 However, few
studies have addressed the antioxidant therapeutic
approaches to block neointima formation, especially in in
vivo models of surgical endarterectomy. In recent years,
a rat CEA model has been established by our group.8,13 In
this model, neointima formation is triggered by surgical
arteriotomy, besides the commonly performed endothelial
denudation. Our findings confirm higher nitro-oxidative
stress in association with increased proliferation of vascular
smooth muscle cells after CEA, as assessed by NT and PCNA
immunostainings, TUNEL assay, lipid hydroperoxidase assay
and RT-qPCR of NOX-4 and SOD-1 genes. SOD mimetic and
peroxynitrite scavenger MnTBAP reduced neointima
formation in rat carotid arteries, accompanied by loweral (A) and neointimal (B) layer of the carotids. Representative
trol CEA (D, nZ 10) and treatment (E, nZ 9) groups. *p< 0.05
Figure 5 Effect of carotid endarterectomy and manganese(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP) treatment on the
relative expression of eNOS (A, endothelial nitric oxide synthase), TGFb1 (B, transforming growth factor b1), NOX-4 (C, nico-
tinamide adenine dinucleotide phosphate oxidase 4), SOD-1 (D, superoxide dismutase-1), c-JUN (E, c-JUN proto-oncogene), c-
FOS (F, c-FOS protooncogene), MMP-2 (G, matrix-metalloproteinase-2) and MMP-9 (H, matrix-metalloproteinase-9) mRNA
expression in the carotid arteries of the sham (nZ 5), acute injury (nZ 4), control CEA (nZ 5) and CEAþMnTBAP (nZ 4)
groups. In any case, b-actin as reference gene was used. *p< 0.05 vs. sham; #p< 0.05 vs. control CEA.
MnTBAP Protects Against Neointima Formation 173nitro-oxidative stress,- as predominantly shown in vascular
media and in the plasma- and reduced VSMC proliferation
rate.
Three weeks after CEA, almost 50% luminal stenosis was
developed by the growing neointima. This is in line with the
results of our previous work, where a comparable amount
of neointimal hyperplasia could be observed in the control
CEA group.13 Neointima/media area ratio is the most
accurate way for morphometric analysis that considers
small changes in vessel diameters caused by the surgery but
that is independent of neointima formation. In neointima/
media area ratio, we observed a threefold decrease in the
treatment group.
As described in previous works, NO and superoxide
anions generate peroxynitrite, which finally leads to
reduced bioavailability of NO. In addition, endothelial
damage also results in reduced NO formation due to
impaired eNOS activity.8,15 Reduced NO-cyclic guanosinemonophosphate (cGMP) signalling contributes to neointima
formation, while different agents that activate this
pathway have been shown to attenuate this process.13,16
The mechanism, however, is not yet completely under-
stood; it is assumed that reduced migration/proliferation
mediates the beneficial effects of increased NO-cGMP sig-
nalling. On the other hand, peroxynitrite e that is produced
some weeks after injury, when NO output is expected to
rise from regrowing endothelium e stimulates cell signal-
ling pathways involved in proliferation.17e19 Our results
show that endarterectomy-induced peroxynitrite formation
was effectively reduced by MnTBAP, leading to decreased
stenosis formation 3 weeks after endothelial injury. Per-
oxynitrite is able to directly damage lipids, proteins and
DNA, and activate MMPs.20,21 Zhang et al. suggested the
pathophysiological role of oxidative DNA damage in neo-
intima formation.22 In our study, TUNEL, as a nonspecific
assay, has been used to test the nitro-oxidative DNA
174 K. Hirschberg et al.damage during neointima formation. In the control CEA
group, excessive increase of TUNEL-positive medial cell
count was observed, compared with sham, which signifi-
cantly decreased in the CEAþMnTBAP group. The same
tendency was observed in the neointima (the sham group
was not evaluated here because it lacked the neointimal
layer). In addition, we assessed lipid peroxidation by
measuring MDA e the degradation product of poly-
unsaturated fatty acids hydroperoxides e levels in the
blood plasma.23 Since this marker was three times higher in
the control CEA group than in the sham group, we assume
that locally produced ROS/RNS react with plasma lipids,
resulting in increased MDA plasma levels. After treatment
with MnTBAP, MDA decreased to the same level as
measured in the sham group, suggesting an effective
elimination of nitro-oxidative agents.
Interestingly, the lower proliferation rate, and the
decreased oxidative and nitrosative stress (as assessed by
immunohistochemistry) after MnTBAP treatment were
highly significant in the media of the injured carotids, but in
the neointimal layer, only tendencies with lower differ-
ences between the control CEA and CEAþMnTBAP groups
could be shown. These results suggest that medial and
neointimal cells in the injured arteries are differentially
affected by nitro-oxidative stimuli or by the antioxidant
treatment and may use different signalling pathways as
suggested by other authors as well.9
Gene expression seems not to be affected by the
antioxidant MnTBAP, which may suggest a post-trans-
lational effect of this drug, predominantly due to the
decreased level of nitrosative and oxidative agents (e.g.,
decreased NT immunoreactivity, oxidative DNA damage or
lower lipid peroxidation). Despite this, RT-qPCR provided
some interesting data, comparable to those of previously
published works. We observed a highly significant reduc-
tion in eNOS expression in the acute injury group that
indicates a successful endothelial damage during CEA.
Three weeks after surgery, eNOS expression reached the
level of that of the sham group, confirming an effective
re-endothelialisation of the injured arteries.18 Growth
factors such as TGFb1 are important cofactors in prolif-
erating tissues, such as neointima, which is confirmed by
our observation of the twofold elevation in TGFb1 gene
expression 3 weeks after surgery.24 We found a 1.6-fold
up-regulation in vascular NOX-4 that is the main source of
superoxide generation in the vascular wall after injury.
Superoxide can stimulate cell proliferation as suggested
by several former studies.14,25,26 Simultaneously, SOD-1 e
primarily responsible for superoxide elimination in the
vessel wall e was down-regulated in the control CEA
group as compared with sham.27 The overproduced
superoxide anions react with NO, resulting in peroxyni-
trite formation. Furthermore, we observed a rapid up-
regulation of the proto-oncogenes c-Jun and c-Fos in the
carotid arteries 1 h after endarterectomy. As described
by several authors, activation of proto-oncogenes
contributes to the very early phase of neointima forma-
tion; then, their level drops to baseline in the following
stages of restenosis development.28,29 Indeed, we found
c-Jun and c-Fos expression in control CEA group to be
identical to those of the sham group. MMPs play a pivotal
role in neointima formation, by degrading extracellularmatrix components to enable VSMCs to migrate through
the internal elastic lamina. In line with the findings of
Webb et al., we found MMP-2 to be constitutively
produced by normal uninjured (sham) arteries; its level
fell in the early postoperative time (1 h) and increased
afterwards.30 MMP-9 expression was barely detectable in
the sham carotids, was up-regulated 1 h after injury and
was still highly overexpressed at 3-week follow-up.
Limitations
The CEA model used in this study does not resemble the
complex situation of a severely diseased atherosclerotic
artery in a patient. However, the native rat carotid artery is
an established model of intimal hyperplasia.8,13 Knockout
mice models of atherosclerosis also lack direct compara-
bility with the human situation. Further studies with animal
models of atherosclerosis are needed.
Conclusions
This study provides new data for an antioxidant therapeutic
approach of preventing neointimal hyperplasia in a rat CEA
model. The SOD mimetic and peroxynitrite scavenger
MnTBAP attenuated the stenosis formation by decreasing
VSMC proliferation and reducing nitro-oxidative stress.
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